Showing results (851-860 of 999) with videos related to
Sort By:
Pageof 100
Journal of the American College of Cardiology|April 10, 2024
A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin MedicationSteven E Nissen, Howard G Hutchinson, Kathy Wolski, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Liver-to-Atria Inflammatory Axis Driving ArrhythmiaYue Yuan, Shuyue Wang, Jifei Ding, et al.Circulation|December 8, 2021
Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of AtherosclerosisMahmoud Al Rifai, Michael J Blaha, Vijay Nambi, et al.Hypertension (Dallas, Tex. : 1979)|October 29, 2014
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities studyYashashwi Pokharel, Wensheng Sun, James A de Lemos, et al.Diabetes Care|March 8, 2020
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart DiseaseGregory G Schwartz, Lawrence A Leiter, Christie M Ballantyne, et al.Atherosclerosis|November 26, 2013
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT)Gerd Brunner, Eric Y Yang, Anirudh Kumar, et al.The American Journal of Cardiology|June 19, 2017
A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein CholesterolChristie M Ballantyne, Sukrut Shah, Aditi Sapre, et al.Journal of the American Heart Association|November 6, 2023
Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular EventsAustin Deets, Parag H Joshi, Alvin Chandra, et al.JAMA Cardiology|December 20, 2018
Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart StudyAmbarish Pandey, Neil Keshvani, Colby Ayers, et al.European Heart Journal|May 1, 2014
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trialJean-Claude Tardif, Christie M Ballantyne, Philip Barter, et al.Pageof 100